Speech-Language Pathologists in Guilderland, NY Accepting Medicare

9 Speech-Language Pathologists found. Showing 1 - 9

Michelle L Fraser, MS CCC SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 6141 State Farm Rd, Guilderland, NY 12084 Phone: 518-724-7704

Mrs. Robin Jean Anderson, M.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 26 Meadowbrook Apt D, Guilderland, NY 12084 Phone: 518-505-4803

Ms. Emma R Daguanno, MS ED., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 10 New Karner Rd, Guilderland, NY 12084 Phone: 631-790-9025

Mrs. Michele Ann Goldman, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 3 Leda Ln, Guilderland, NY 12084 Phone: 518-469-7357

Ms. Jane Capria Downey, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2280 Western Ave, Guilderland, NY 12084 Phone: 518-452-4239    Fax: 518-452-4239

Ms. Penny Joan Smith-bogert, CCC/SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2225 Western Ave, Guilderland, NY 12084 Phone: 518-869-0293    Fax: 518-464-6458

Mrs. Katie A Giglio, M.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 6072 State Farm Rd, Guilderland, NY 12084 Phone: 518-456-6010

Kelsey M Johnson, CF-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2 Mercy Care Ln, Guilderland, NY 12084 Phone: 518-464-8100

Ms. Susan Rothchild, M.S. Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 6072 State Farm Rd, Guilderland, NY 12084 Phone: 518-456-6010    Fax: 518-456-3747

News Archive

Study analyzes outcomes of brain metastases patients following stereotactic radiosurgery

Winner of the Leksell Radiosurgery Award, Deborah C. Marshall, recently presented her research, Survival Patterns of Patients with Cerebral Metastases after Multiple Rounds of Stereotactic Radiosurgery (SRS), at the 2015 American Association of Neurological Surgeons Annual Scientific Meeting.

EC approves Lilly's ALIMTA as continuation maintenance therapy for NSCLC

Eli Lilly and Company announced today that the European Commission has granted approval for the use of ALIMTA (pemetrexed for injection) as a single agent for continuation maintenance therapy in patients with a particular type of lung cancer, called advanced nonsquamous non-small cell lung cancer

Fair access to recommended drugs in Britain

Health Secretary John Reid has set out plans to ensure patients across the country have equal access to treatments recommended by the independent National Institute for Clinical Excellence (NICE).

Canadians with lung, breast, colorectal or ovarian cancer have higher survival rate

Canadians with lung, breast, colorectal or ovarian cancer have a higher rate of survival than people diagnosed with these cancers in the United Kingdom, Denmark or Norway, a new international study has found.

Read more Medical News

› Verified 6 days ago